Literature DB >> 22947599

Polyvalent immunoglobulin significantly attenuated the formation of IL-1β in Escherichia coli-induced sepsis in pigs.

Andreas Barratt-Due1, Andrey Sokolov, Alice Gustavsen, Bernt Christian Hellerud, Kjetil Egge, Soeren Erik Pischke, Julie Katrine Lindstad, Anne Pharo, Albert Castellheim, Ebbe Billmann Thorgersen, Tom Eirik Mollnes.   

Abstract

Evidence suggests that adjunctive treatment with intravenous immunoglobulin preparations enriched with IgA and IgM reduce mortality in sepsis. The mode of action of polyvalent immunoglobulin is complex, including neutralization of toxins and modulation of complement activation and cytokine formation toward an anti-inflammatory profile. In this study we explored the effect of Pentaglobin, containing IgG, IgA and IgM, on the initial inflammatory reaction as well as on hemodynamics, using a well characterized and standardized porcine model of sepsis. Anesthetized and mechanically ventilated pigs, mean weight 14.9 kg, were allocated into two groups of 8 animals, receiving either Pentaglobin or saline, before sepsis was induced by intravenous Escherichia coli infusion. Five negative controls received saline only. All animals were observed for 4 h under extensive invasive monitoring. Pentaglobin significantly (p < 0.05) attenuated IL-1β formation by 38% at the end of the experiment, and markedly increased (p < 0.05) the formation of IL-10 at 60 min. TNF-α, IL-6, IL-8 and expression of the cell surface marker wCD11R3 were lower in the Pentaglobin group, but the differences were not significant. The serum concentration of LPS was three times higher in the Pentaglobin group (p < 0.005), indicating binding of LPS to Pentaglobin. Complementary in vitro experiments showed a higher binding affinity for IgM and IgA to LPS than for IgG. LPS-induced formation of IL-6 was significantly (p < 0.05) attenuated by Pentaglobin in an in vitro whole blood model. In conclusion, Pentaglobin decreased the key inflammasome IL-1β molecule in an E. coli-model of pigs sepsis.
Copyright © 2012 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22947599     DOI: 10.1016/j.imbio.2012.08.268

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  9 in total

1.  Neuroinflammatory Nexus of Pediatric Epilepsy.

Authors:  Shruti Bagla; Alan A Dombkowski
Journal:  J Pediatr Epilepsy       Date:  2018-09-03

Review 2.  Best-practice IgM- and IgA-enriched immunoglobulin use in patients with sepsis.

Authors:  Axel Nierhaus; Giorgio Berlot; Detlef Kindgen-Milles; Eckhard Müller; Massimo Girardis
Journal:  Ann Intensive Care       Date:  2020-10-07       Impact factor: 6.925

Review 3.  Sepsis-Pathophysiology and Therapeutic Concepts.

Authors:  Dominik Jarczak; Stefan Kluge; Axel Nierhaus
Journal:  Front Med (Lausanne)       Date:  2021-05-14

4.  In vitro and in vivo activity of hyperimmune globulin preparations against multiresistant nosocomial pathogens.

Authors:  F S Rossmann; A Kropec; D Laverde; F R Saaverda; D Wobser; J Huebner
Journal:  Infection       Date:  2014-11-27       Impact factor: 3.553

5.  Vitamin E-Coated Polysulfone Membrane-Based Hemodiafiltration Attenuates Inflammation in a Rat Model of Lipopolysaccharide-Induced Systemic Inflammation.

Authors:  Yoshihiro Hatanaka; Satoru Inoue; Koji Goto; Norihisa Yasuda; Seigo Hidaka; Takaaki Kitano
Journal:  Iran J Med Sci       Date:  2017-09

Review 6.  Approaches for Controlling Antibody-Mediated Allograft Rejection Through Targeting B Cells.

Authors:  Yoshiko Matsuda; Takeshi Watanabe; Xiao-Kang Li
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

7.  IgM-Enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis: A Before-After Cohort Study.

Authors:  Saskia Wand; Matthias Klages; Christin Kirbach; Joanna Warszawska; Patrick Meybohm; Kai Zacharowski; Alexander Koch
Journal:  PLoS One       Date:  2016-08-09       Impact factor: 3.240

8.  IgM-enriched solution BT086 improves host defense capacity and energy store preservation in a rabbit model of endotoxemia.

Authors:  S Shmygalev; M Damm; L Knels; A Strassburg; K Wünsche; R Dumke; S N Stehr; T Koch; A R Heller
Journal:  Acta Anaesthesiol Scand       Date:  2015-11-11       Impact factor: 2.105

Review 9.  Use of Intravenous Immunoglobulins in Sepsis Therapy-A Clinical View.

Authors:  Dominik Jarczak; Stefan Kluge; Axel Nierhaus
Journal:  Int J Mol Sci       Date:  2020-08-03       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.